TTM
$3.57B
YoY change
+6.0%
5Y CAGR
+9.7%
Peak year (2025)
$3.60B
Cumulative operating income
$30.91B
Operating Income history chart for Zoetis (ZTS) from 2009 to 2025
Latest: $3.60B
Operating Income growth chart for Zoetis (ZTS) from 2009 to 2025
Latest: +6.0%
Operating Income history table for Zoetis (ZTS) from 2009 to 2025
| 2025 | $3.60B | +6.0% | +$205.00M | ||
| 2024 | $3.39B | +10.5% | +$323.00M | ||
| 2023 | $3.07B | +4.8% | +$141.00M | ||
| 2022 | $2.93B | +4.5% | +$125.00M | ||
| 2021 | $2.80B | +23.5% | +$534.00M | ||
| 2020 | $2.27B | +12.4% | +$251.00M | ||
| 2019 | $2.02B | +7.3% | +$137.00M | ||
| 2018 | $1.88B | +8.9% | +$154.00M | ||
| 2017 | $1.73B | +23.0% | +$323.00M | ||
| 2016 | $1.40B | +29.8% | +$322.00M | ||
| 2015 | $1.08B | +11.5% | +$112.00M | ||
| 2014 | $970.00M | +18.1% | +$149.00M | ||
| 2013 | $821.00M | -3.9% | −$33.00M | ||
| 2012 | $854.00M | +24.9% | +$170.00M | ||
| 2011 | $684.00M | +121.4% | +$375.00M | ||
| 2010 | $309.00M | +10.0% | +$28.00M | ||
| 2009 | $281.00M | — | — |
- 2025$3.60B+6.0%
- 2024$3.39B+10.5%
- 2023$3.07B+4.8%
- 2022$2.93B+4.5%
- 2021$2.80B+23.5%
- 2020$2.27B+12.4%
- 2019$2.02B+7.3%
- 2018$1.88B+8.9%
- 2017$1.73B+23.0%
- 2016$1.40B+29.8%
- 2015$1.08B+11.5%
- 2014$970.00M+18.1%
- 2013$821.00M-3.9%
- 2012$854.00M+24.9%
- 2011$684.00M+121.4%
- 2010$309.00M+10.0%
- 2009$281.00M—
Operating Income values are taken from Zoetis's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at Zoetis (ZTS)
According to Zoetis's latest reported financial statements, the company's current operating income (TTM) is $3.57B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual operating income for Zoetis (ZTS) came in at $3.60B – grew 6.0% year-over-year.
Through 2020–2025 (5 years), Zoetis operating income delivered a +9.7% annualised rate; sustaining 12 straight years of year-over-year growth.
The highest annual operating income of $3.60B was reported in 2025. The lowest in the available history was $281.00M in 2009.
Zoetis Operating Income by Year
Zoetis Operating Income 2025: $3.60B
Zoetis operating income in 2025 was $3.60B, grew 6.0% from 2024. This figure represents the highest annual value in the available history.
Zoetis Operating Income 2024: $3.39B
2024's operating income for Zoetis came in at $3.39B, grew 10.5% from 2023.
Zoetis Operating Income 2023: $3.07B
Zoetis posted operating income of $3.07B in 2023, edged up 4.8% from 2022.
Zoetis Operating Income 2022: $2.93B
In 2022, Zoetis reported operating income of $2.93B, edged up 4.5% from 2021.
Zoetis Operating Income 2021: $2.80B
Zoetis operating income in 2021 was $2.80B.
See more financial history for Zoetis (ZTS).
Sector peers by Operating Income
Healthcare peers of Zoetis (ZTS), ranked by their latest operating income
| $29.70B | |
| $25.60B | |
| $23.49B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B |
- $29.70B
- $25.60B
- $23.49B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
Zoetis (ZTS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation